
Sign up to save your podcasts
Or


This episode covers insights from the Strategy Catalyst Summit (Feb 2025), covering direct-to-employer healthcare partnerships, Washington policy shifts under Trump, cybersecurity threats, and urgent care strategies for improving payer mix. The episode also discusses Novo Nordisk and Eli Lilly's direct-to-consumer GLP-1 delivery platforms, conservative estimates of $1.1 trillion in Medicaid improper payments over the past decade, and UnitedHealth Group's legal victory against DOJ allegations of $2 billion in Medicare Advantage overpayments.
By The Health Management AcademyThis episode covers insights from the Strategy Catalyst Summit (Feb 2025), covering direct-to-employer healthcare partnerships, Washington policy shifts under Trump, cybersecurity threats, and urgent care strategies for improving payer mix. The episode also discusses Novo Nordisk and Eli Lilly's direct-to-consumer GLP-1 delivery platforms, conservative estimates of $1.1 trillion in Medicaid improper payments over the past decade, and UnitedHealth Group's legal victory against DOJ allegations of $2 billion in Medicare Advantage overpayments.